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SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comby 20% indicating reduction of LV ﬁlling pressure, the LVEF by Teicholz increased
from 39% up to 45% (15%), by Simpson decreased from 45% to 40% by reducing
8.8%, cardiac output decreased from 2.61 l/min to 2.31 l/min during balloon
inﬂation.
Conclusions: We are reporting the ﬁrst experience in humans of a new method for
intermittent preload reduction in patients with CHF. The beneﬁcial hemodynamic and
echocardiographic changes obtained in this patient suggest that this new procedure
may play role in the treatment of patients with CHF. Large studies are needed to
further evaluate this new procedure.
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Background: There is a paucity of data regarding the feasibility, safety and efﬁcacy
of fetal pulmonary valvuloplasty (FPV) for pulmonary atresia or stenosis with intact
interventricular septum (PA/PS/IVS) and evolving hypoplastic right heart syndrome
(HRHS) diagnosed in-utero. We report in-utero and post natal outcomes of this
procedure.
Methods: FPV was performed under maternal spinal anesthesia and fetal general
anesthesia by a multi-disciplinary team under echo monitoring. A 15 cm long 17 G
Chiba needle was used to access the apex of the RV. The pulmonary valve (PV) was
perforated (when atretic) either with the needle or using a stiff coronary wire. Pre-
mounted systems with coronary balloons (1.2-1.5 times the valve annulus) over
coronary wires were advanced.
Results: From 01/08, 10 fetuses (6 PS/ 4 PA; mean age: 27  2 weeks) underwent
11 procedures. There were 2 failures 2. One had a successful repeated procedure
2 weeks afterwards. There were no maternal complications. The valve was suc-
cessfully crossed and dilated in 9 with echo evidence of forward ﬂow and pulmonary
insufﬁciency. Ductal spasm was observed in 4. Pericardial effusion requiring
drainage was observed in all but one patient. One patient was born at elsewhere and
underwent a BTT shunt and is now 3 months. Two fetuses are still in-utero. Six
patients were born at our center and underwent neonatal pulmonary valvuloplasty
and ductal stenting and were followed over a median post-natal period of 12 months
(6-48). In these patients there was a signiﬁcant and progressive increase in RV size
(Z value of the TV, RV length) from the initial in-utero to the last echo assessment
and all achieved an eventual BVC and spontaneous closure of the ductal stent with
Sats > 90%.
Conclusions: FPV followed by neonatal valvuloplasty and ductal stenting was an
effective means to achieve adequate RV growth and a BVC in fetuses with PA/PS/IVS
and evolving HRHS. FPV is technically demanding and frequently results in peri-
cardial effusion requiring drainage. The procedure seems to be safe to the mother.
More patients are needed to draw stronger conclusions.
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Background: Degradation of bioabsorbable stents (BAS) has been shown to allow
restoration of the treated segment’s plasticity and reactivity to those resembling a non-
stented artery, a desirable feature unattainable with metallic stents (BMS). We aimed
to evaluate by OCT the long term dynamic changes in arterial geometry in response to
a novel non-drug eluting BAS as compared to BMS.
Methods: Thirty-ﬁve coronary arteries of 13 swine received BAS (Amaranth Medical,
Mountain View, CA n¼22) or BMS (Liberte Boston Scientiﬁc, Natick, MA n¼13).
Optical coherence tomography (OCT) was done at day 0, day 28 (BAS, n¼22; BMS,
n¼13), 1 year and 2 years (BAS, n¼6; BMS, n¼4).
Results: The lumen areas of reference segments increased over time, but less for the
BMS-caged segments (Day 0¼6.11.8mm2, 2 Years¼10.62.9mm2) than for the
BAS-treated arteries (Day 0¼6.71.9mm2, 2 Years¼12.10.4mm2). BMS showed
lumen area loss at 28 days as expected due to neointimal formation, and then minimal
lumen area variance over time up to 2 years (Day 0¼6.791.7mm2, 2
Years¼6.782.25mm2). In contrast, in BAS the early lumen area loss present at 28
days inverted into lumen gain that corresponded with the scaffold mechanics paral-
leling the artery growth and allowing the treated segment to remodel (Day
0¼7.310.9mm2, 2 Years¼9.711.58mm2, Figure).B126 JACC Vol 64/11/Suppl B jConclusions: Restoration of the treated segment’s ability to grow and remodel, with
late lumen area gain as a consequence, appear to be a reproducible and inherent
pattern of non-drug eluting bioabsorbable stent behavior in the porcine coronary
model.
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Background: We designed the ﬁrst poly-L-lactic acid XINSORB scaffold in China.
Long-term morphological results of this kind of scaffold were explored in a porcine
coronary model.
Methods: XINSORB scaffold (3.0mm in diameter and 15mm in length) were
implanted into porcine coronary arteries with a reference vessel diameter ranging from
2.5 to 2.8mm, using a 1.1:1 stent-to-artery ratio. Angiogram and optical coherence
tomography (OCT) test were performed after implantation and at 1, 3, 12, and 18-
month follow-up.
Results: Total 28 mini pigs were enrolled and 56 scaffolds were deployed. At 1, 3, 12,
and 18-month, 8, 8, 10, and 10 scaffolds were examined respectively. Angiogram after
procedure showed that proximal, in-scaffold, and distal minimal luminal diameter
were 2.930.28mm, 2.780.26mm and 2.730.30mm. The corresponding percent-
age of diameter stenosis (%DS) was 5.74.0%, 7.04.1% and 6.74.1% respec-
tively. At 1-month follow-up, proximal, in-scaffold, and distal late luminal loss (LLL)
of scaffold were 0.530.41mm, 0.680.42mm and 0.650.24mm, while %DS were
9.57.7%, 17.616.8% and 10.57.4%. At 3-month, proximal, in-scaffold, and
distal LLL were 0.230.48mm, 0.770.48mm and 0.110.35mm, while %DS were
14.59.4%, 31.913.6% and 5.43.6%. At 12-month, proximal, in-scaffold, and
distal LLL were -0.130.45mm, 0.280.41mm and 0.180.48mm, while %DS were
2.42.9%, 14.19.1% and 8.68.7%. At 18-month, proximal, in-scaffold, and distal
LLL were 0.370.57mm, 0.090.31mm and -0.010.41mm, while %DS were
3.94.6%、13.77.3% and 6.95.2%. OCT demonstrated that luminal area, scaffold
area, neointimal area and percentage of area stenosis were 5.951.63mm2,
8.081.16mm2, 2.120.67mm2 and 25.810.6% at 1 month, 4.020.96mm2,
7.910.53mm2, 2.890.45mm2 and 37.99.7% at 3 month, 5.960.82mm2,
8.090.74mm2, and 2.070.36mm2 and 24.17.3% at 12 month and
6.840.77mm2, 8.740.82mm2, 1.940.56mm2 and 19.76.9% at 18 month.
Preserved box of scaffold was 100%, 97.6%, 92.1% and 89.4% at each time point.
Conclusions: Neointimal hyperplasia of XINSORB scaffold was prominent at 3-
month. After that, LLL and %DS were noticeably reduced. LA at 18-month was
signiﬁcantly larger than that at 3-month with a constant scaffold area.
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Background: Ischemia-reperfusion injury (IRI) remains a major determinant of
mortality in acute myocardial infarction (AMI). Stromal cell-derived factor-1 (SDF-1)
is a chemokine that promotes myocardial salvage by activating cardioprotective
signaling via Akt, ERK, and STAT-3. No studies have targeted initially reducing left
ventricular stroke work (LVSW) to limit IRI in AMI. The Impella CP axial-ﬂow pump
reduces LVSW. We tested the hypothesis that ﬁrst reducing myocardial work and
delaying coronary reperfusion reduces infarct size by activating cardioprotective
signaling pathways.
Methods: AMI was induced by occlusion of the left anterior descending artery (LAD)
via angioplasty for 90 minutes in 50kg male Yorkshire swine (n¼5/group). In Group
1, the LAD was reperfused for 120 minutes. In Group 2, after 90 minutes of ischemia
the Impella CP device was activated and the LAD left occluded for an additional 60
minutes (150 minutes of LAD occlusion total), followed by 120 minutes of reperfu-
sion. The Impella CP was active throughout reperfusion. Western blot analysis
quantiﬁed myocardial kinase activity.September 13–17, 2014 j TCT Abstracts/New Devices and Innovation
